Search

Displaying results 6971 - 6980 of 10000 in total
  1. Drug

    Human papillomavirus type 16 L1 capsid protein antigen

    go.drugbank.com/drugs/DB10301
    ApprovedInvestigational

    It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV) types 6, 11, 16 and 18. … The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, and 18, which are produced by separate fermentations in recombinant *Saccharomyces

  2. Drug

    Human papillomavirus type 18 L1 capsid protein antigen

    go.drugbank.com/drugs/DB10302
    ApprovedInvestigational

    It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV) types 6, 11, 16 and 18. … The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, and 18, which are produced by separate fermentations in recombinant *Saccharomyces

  3. Drug

    Tienopramine

    go.drugbank.com/drugs/DB19796
    Experimental

    The usage of the INN stem '-pramine' in the name indicates that Tienopramine is a substance of the imipramine group. Tienopramine has a monoisotopic molecular weight of 284.13 Da.

  4. Drug

    Carpipramine

    go.drugbank.com/drugs/DB20320
    Experimental

    The usage of the INN stem '-pramine' in the name indicates that Carpipramine is a substance of the imipramine group. Carpipramine has a monoisotopic molecular weight of 446.3 Da.

  5. Drug

    Zegruvirimat

    go.drugbank.com/drugs/DB21535
    Experimental

    The usage of the INN stem '-virimat' in the name indicates that Zegruvirimat is a antiviral, disruptor of viral maturation. Zegruvirimat has a monoisotopic molecular weight of 826.51 Da.

  6. Drug

    Iprindole

    go.drugbank.com/drugs/DB13496
    Experimental

    Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Non-Selective Monoamine Reuptake Inhibitors
  7. Drug

    Loprazolam

    go.drugbank.com/drugs/DB13643
    Experimental

    It is indicated for the short-term treatment of insomnia including difficulty in falling asleep and/or frequent nocturnal awakenings. … It is a positive modulator of GABA-A receptor that enhances the inhibitory neurotransmission. It is not an FDA-approved drug.

  8. Drug

    Crobenetine

    go.drugbank.com/drugs/DB21095
    Investigational

    Crobenetine has a monoisotopic molecular weight of 379.25 Da. … Crobenetine is under investigation in clinical trial NCT02273466 (Pharmacokinetics of Oral Desipramine With and Without Concomitant Administration of Crobenetine Infusion in Healthy Male Subjects).

  9. Drug

    Nizubaglustat

    go.drugbank.com/drugs/DB21603
    Investigational

    Nizubaglustat has a monoisotopic molecular weight of 433.23 Da. … C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis).

  10. Drug

    Cabiotraxetan

    go.drugbank.com/drugs/DB20465
    Experimental

    The usage of the INN stem '-xetan' in the name indicates that Cabiotraxetan is a chelating agent. Cabiotraxetan has a monoisotopic molecular weight of 714.41 Da.